| Dr Nancy Buset, OD | |
|
13180 Se 169th Ave Ste 104, Happy Valley, OR 97086 | |
| (503) 698-2375 | |
| (503) 698-3398 |
| Full Name | Dr Nancy Buset |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 13180 Se 169th Ave Ste 104, Happy Valley, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447306360 | NPI | - | NPPES |
| R0000WDBCW | Other | MEDICARE GROUP PIN | |
| 1508037607 | Other | ORGANIZATION (GROUP) NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2826ATI (Oregon) | Primary |
| 152WP0200X | Optometrist - Pediatrics | 2628ATI (Oregon) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gresham Vision Center Inc | 8820061401 | 2 |
News Archive
Smokers can add pre-cancerous growths in the colon to the host of increased health risks they face, according to two studies presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.
Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial. Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by asbestos.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
› Verified 4 days ago
| Provider Name | Double Vision Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508037607 PECOS PAC ID: 0143291161 Enrollment ID: O20040803001701 |
News Archive
Smokers can add pre-cancerous growths in the colon to the host of increased health risks they face, according to two studies presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.
Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial. Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by asbestos.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
› Verified 4 days ago
| Provider Name | Gresham Vision Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619022076 PECOS PAC ID: 8820061401 Enrollment ID: O20040813000274 |
News Archive
Smokers can add pre-cancerous growths in the colon to the host of increased health risks they face, according to two studies presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.
Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial. Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by asbestos.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
› Verified 4 days ago
| Provider Name | Spectrum Eye Care Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043969579 PECOS PAC ID: 9234525783 Enrollment ID: O20220408001412 |
News Archive
Smokers can add pre-cancerous growths in the colon to the host of increased health risks they face, according to two studies presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.
Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial. Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by asbestos.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Buset, OD 13180 Se 169th Ave Ste 104, Happy Valley, OR 97086-8727 Ph: (503) 997-6763 | Dr Nancy Buset, OD 13180 Se 169th Ave Ste 104, Happy Valley, OR 97086 Ph: (503) 698-2375 |
News Archive
Smokers can add pre-cancerous growths in the colon to the host of increased health risks they face, according to two studies presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.
Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial. Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by asbestos.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
› Verified 4 days ago
Pacific Eye Group, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12000 Se 82nd Ave Ste 2193, Happy Valley, OR 97086 Phone: 425-329-2722 | |
Keith L Miller, Od, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11800 Se 82nd Ave, Happy Valley, OR 97086 Phone: 503-786-5235 | |
Dr. Samuel Edward Adelman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11800 Se 82nd Ave, Happy Valley, OR 97086 Phone: 503-660-3093 Fax: 503-654-5429 | |
Spectrum Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 13180 Se 169th Ave Ste 104, Happy Valley, OR 97086 Phone: 503-698-2375 Fax: 503-251-3761 | |
Dr. Kevin Gia-minh Phan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12000 Se 82nd Ave Ste 2193, Happy Valley, OR 97086 Phone: 503-654-6217 Fax: 503-654-9335 | |
Dr. Dominic Jerome Dorazio, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 12050 Se Stevens Rd Ste 100, Happy Valley, OR 97086 Phone: 503-656-4221 | |
Dr. William Bert Berk Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 13180 Se 169th Ave Ste 104, Happy Valley, OR 97086 Phone: 503-698-2375 Fax: 503-698-3398 |